Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: some nuances

Gerardo Aguilar; Rafael Ferriols; Sara Martínez-Castro; Carlos Ezquer; Ernesto Pastor; Jose A Carbonell; Manuel Alós; David Navarro

doi:10.1186/s13054-019-2724-y

Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: some nuances

Crit Care. 2020 Jan 10;24(1):11. doi: 10.1186/s13054-019-2724-y.

Authors

Gerardo Aguilar^{1

2

3}, Rafael Ferriols^{4

5

6}, Sara Martínez-Castro⁷, Carlos Ezquer^{5

6}, Ernesto Pastor⁷, Jose A Carbonell⁷, Manuel Alós^{4

5

6}, David Navarro^{4

5

8}

Affiliations

¹ Critical Care Unit, Anesthesiology and Critical Care Department, Hospital Clínico Universitario de Valencia, Valencia, Spain. [email protected].
² INCLIVA Health Research Institute, Avenida de Menéndez y Pelayo, 4, 46010, Valencia, Spain. [email protected].
³ School of Medicine, University of Valencia, Avenida Blasco Ibáñez, 15, 46010, Valencia, Spain. [email protected].
⁴ INCLIVA Health Research Institute, Avenida de Menéndez y Pelayo, 4, 46010, Valencia, Spain.
⁵ School of Medicine, University of Valencia, Avenida Blasco Ibáñez, 15, 46010, Valencia, Spain.
⁶ Department of Pharmacy, Hospital Clínico Universitario de Valencia, Avenida Blasco Ibáñez, 17, 46010, Valencia, Spain.
⁷ Critical Care Unit, Anesthesiology and Critical Care Department, Hospital Clínico Universitario de Valencia, Valencia, Spain.
⁸ Department of Microbiology, Hospital Clínico Universitario de Valencia, Avenida Blasco Ibáñez, 17, 46010, Valencia, Spain.

No abstract available

Publication types

Letter
Comment

MeSH terms

Cephalosporins*
Continuous Renal Replacement Therapy*
Tazobactam

Substances

Cephalosporins
ceftolozane
Tazobactam